Semaglutide's Weight Loss Effects in Obesity

• Status: NOT_YET_RECRUITING
• Trial end date: 2027-12-31

Summary

This is a non-randomized, concurrent, parallel-controlled clinical trial. The objective of this trial is to determine the relationship between weight loss responsiveness to semaglutide in obese patients and their gut microbiota.

• Phase: NA

Details

• Lead Sponsor: Beijing Chao Yang Hospital